Medline, Inc. (MDLN)
35.75
+0.20
(+0.56%)
USD |
NASDAQ |
Oct 07, 13:17
Medline Gross Profit Margin (Quarterly) : 26.52% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.52% |
| March 31, 2026 | 22.65% |
| December 31, 2025 | 22.32% |
| September 30, 2025 | 23.87% |
| June 30, 2025 | 25.11% |
| Date | Value |
|---|---|
| March 31, 2025 | 24.82% |
| December 31, 2024 | 24.68% |
| September 30, 2024 | 24.80% |
| June 30, 2024 | 24.16% |
| March 31, 2024 | 25.02% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Insulet Corp. | 72.56% |
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 50.87% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.79% |
| Return on Assets | 2.31% |
| Return on Invested Capital | 2.69% |
| Profit Margin (Quarterly) | 1.81% |
| Operating Margin (Quarterly) | 5.52% |
| Return on Net Operating Assets | 2.60% |